SHPH
Shuttle Pharmaceuticals Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.72
−7.09%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +19.0%
- EBIT
- +4.0%
- EPS
- +25.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- -46.0%
- EBIT
- -54.8%
- Net income
- -28.2%
- EPS
- +99.2%
- Free cash flow
- -29.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026